GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,560,000 | -44.3% | 800,000 | -39.6% | 2.16% | +5.0% |
| Q1 2022 | $45,898,000 | +18.3% | 1,325,000 | 0.0% | 2.06% | +88.3% |
| Q4 2021 | $38,783,000 | -20.9% | 1,325,000 | -31.2% | 1.09% | -10.5% |
| Q3 2021 | $49,049,000 | +6.9% | 1,925,000 | +46.9% | 1.22% | +4.8% |
| Q2 2021 | $45,876,000 | +25.1% | 1,310,000 | +45.6% | 1.16% | +6.7% |
| Q1 2021 | $36,675,000 | -1.5% | 900,000 | +4.7% | 1.09% | -1.0% |
| Q4 2020 | $37,247,000 | +71.0% | 860,000 | +117.7% | 1.10% | +13.1% |
| Q3 2020 | $21,780,000 | +15.0% | 395,000 | +31.7% | 0.98% | -13.0% |
| Q2 2020 | $18,939,000 | +23.6% | 300,000 | 0.0% | 1.12% | -31.1% |
| Q1 2020 | $15,327,000 | -35.7% | 300,000 | 0.0% | 1.63% | -25.8% |
| Q4 2019 | $23,847,000 | -99.8% | 300,000 | 0.0% | 2.19% | +45.6% |
| Q3 2019 | $14,556,000,000 | -7.8% | 300,000 | 0.0% | 1.51% | +2.0% |
| Q2 2019 | $15,780,000,000 | +99276.5% | 300,000 | 0.0% | 1.48% | -15.3% |
| Q1 2019 | $15,879,000 | +10.5% | 300,000 | -14.3% | 1.74% | -29.0% |
| Q4 2018 | $14,368,000 | -14.1% | 350,000 | -20.5% | 2.46% | +21.0% |
| Q3 2018 | $16,720,000 | -30.2% | 440,000 | -17.0% | 2.03% | -39.3% |
| Q2 2018 | $23,956,000 | -17.3% | 530,000 | -11.7% | 3.35% | -34.3% |
| Q1 2018 | $28,980,000 | +43.0% | 600,000 | +16.5% | 5.10% | +3.3% |
| Q4 2017 | $20,265,000 | +71.8% | 515,000 | +35.5% | 4.94% | +48.1% |
| Q3 2017 | $11,799,000 | +100.7% | 380,000 | +76.7% | 3.33% | +53.2% |
| Q2 2017 | $5,880,000 | +57.2% | 215,000 | +111.8% | 2.18% | -1.4% |
| Q1 2017 | $3,740,000 | -14.9% | 101,500 | -66.6% | 2.21% | -39.2% |
| Q4 2016 | $4,393,000 | -20.6% | 304,000 | +26.7% | 3.63% | -19.0% |
| Q3 2016 | $5,532,000 | -22.5% | 240,000 | -44.2% | 4.48% | -36.9% |
| Q2 2016 | $7,134,000 | +328.5% | 430,000 | +309.5% | 7.10% | +271.6% |
| Q1 2016 | $1,665,000 | -20.8% | 105,000 | +61.5% | 1.91% | +3.0% |
| Q4 2015 | $2,101,000 | – | 65,000 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |